BI 764532 clinical trials

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy

This study is for adults with a type of lung cancer called small cell lung cancer that has spread. It checks how well a new medicine called BI 764532, given with standard chemotherapy, is tolerated. The main goal is to find the safest dose of BI 764532.